ORTHOCELL LIMITED - Announcements

Market Cap $145.8M Add to my watchlist

Healthcare Biotechnology

Orthocell Limited is an Australia-based regenerative medicine company. The Company is... Orthocell Limited is an Australia-based regenerative medicine company. The Company is focused on regenerating mobility for patients by developing products for the repair of a variety of bone and soft tissue injuries. Its portfolio of products includes Striate+, Remplir, and OrthoACI. Striate+ is a sterile, resorbable collagen membrane used for guided bone and tissue regeneration in dental applications. Remplir is a collagen scaffold used in peripheral nerve repair. OrthoACI or autologous chondrocyte implantation is used for the treatment of articular cartilage defects in the knee and ankle. OrthoACI uses the patient’s own healthy cartilage cells called chondrocytes to assist the regeneration of damaged cartilage. The Company is engaged in the development of its tendon cell therapy in the United States. Its autologous tendon therapy is an advanced injectable cellular therapy for the treatment of chronic tendon injuries.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

OCC	Date of AGM & Closing Date for Director Nominations		04/09/23	110.36KB	Share
OCC	Appendix 4G		31/08/23	283.2KB	Share
OCC	Corporate Governance Statement		31/08/23	318.09KB	Share
OCC	Appendix 4E & Annual Report	PRICE SENSITIVE	31/08/23	6.17MB	Share
OCC	Striate re-certified under new European medical device regs	PRICE SENSITIVE	24/08/23	187.74KB	Share
OCC	Quarterly Activity Report & Appendix 4C	PRICE SENSITIVE	31/07/23	619.49KB	Share
OCC	Orthocell receives A$3.17m R&D tax incentive refund	PRICE SENSITIVE	21/06/23	192.17KB	Share
OCC	Change of Director's Interest Notice - Paul Anderson		16/06/23	196.24KB	Share
OCC	Change of Director's Interest Notice - Paul Anderson		13/06/23	196.29KB	Share
OCC	Initial Director's Interest Notice - John Van Der Wielen		01/06/23	243.04KB	Share
OCC	Proposed issue of securities - OCC		29/05/23	24.81KB	Share
OCC	Notification regarding unquoted securities - OCC		29/05/23	29.37KB	Share
OCC	John Van Der Wielen appointed Independent Non-Exec Chair		29/05/23	230.27KB	Share
OCC	Option Terms and Conditions		26/05/23	176.17KB	Share
OCC	Notification regarding unquoted securities - OCC		26/05/23	32.74KB	Share
OCC	Quarterly Activity Report & Appendix 4C	PRICE SENSITIVE	27/04/23	453.45KB	Share
OCC	Cleansing Notice		19/04/23	147.23KB	Share
OCC	Application for quotation of securities - OCC		19/04/23	25.11KB	Share
OCC	Notification regarding unquoted securities - OCC		19/04/23	31.68KB	Share
OCC	Orthocell commences nerve repair study	PRICE SENSITIVE	18/04/23	204.15KB	Share
OCC	Leading US-based nerve surgeons appointed to advisory board	PRICE SENSITIVE	29/03/23	169.54KB	Share
OCC	Initial Director's Interest Notice-RT		08/03/23	241.27KB	Share
OCC	Notification regarding unquoted securities - OCC		08/03/23	28.09KB	Share
OCC	Orthocell Appoints Non-Executive Director Dr Ravi Thadhani		08/03/23	231.18KB	Share
OCC	Orthocell appoints Company Secretary Mr Peter Webse		01/03/23	132.61KB	Share
OCC	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/23	4.16MB	Share
OCC	Investor Presentation		02/02/23	12.22MB	Share
OCC	Appendix 4C - Quarterly	PRICE SENSITIVE	30/01/23	456.15KB	Share
OCC	Change of Director's Interest Notice PA		23/11/22	196.01KB	Share
OCC	Change of Director's Interest Notice LL		23/11/22	197.93KB	Share
OCC	Notification of cessation of securities - OCC		23/11/22	22.56KB	Share
OCC	Notification of cessation of securities - OCC		23/11/22	22.49KB	Share
OCC	Change of Director's Interest Notice LL Revised		11/11/22	320.85KB	Share
OCC	Change of Director's Interest Notice LL		09/11/22	198.1KB	Share
OCC	Remplir Gains Australian Reimbursement	PRICE SENSITIVE	01/11/22	299.94KB	Share
OCC	Appendix 4C - Quarterly	PRICE SENSITIVE	31/10/22	442.67KB	Share
OCC	Results of Meeting		28/10/22	140.26KB	Share
OCC	Investor Presentation		26/10/22	5.72MB	Share
OCC	OrthoATI Rotator Cuff Study Success With Cross-Over Patients	PRICE SENSITIVE	29/09/22	273.87KB	Share
OCC	Letter to Shareholders - Annual General Meeting		28/09/22	727.9KB	Share
OCC	Notice of Annual General Meeting/Proxy Form		28/09/22	851.1KB	Share
OCC	First orders for Striate and Remplir	PRICE SENSITIVE	27/09/22	185.26KB	Share
OCC	Appointment of Exclusive Australian Distributor for Remplir	PRICE SENSITIVE	07/09/22	328.63KB	Share
OCC	Trading Halt	PRICE SENSITIVE	06/09/22	564.01KB	Share
OCC	Annual General Meeting		05/09/22	151.23KB	Share
OCC	Appendix 4G		31/08/22	304.06KB	Share
OCC	Final Report and Annual Report to Shareholders	PRICE SENSITIVE	31/08/22	5.09MB	Share
OCC	Notice under Section 708(A) of the Corporations Act		17/08/22	146.15KB	Share
OCC	Notification of cessation of securities - OCC		17/08/22	22.54KB	Share
OCC	Application for quotation of securities - OCC		17/08/22	26.67KB	Share
OCC	Appendix 4C - Quarterly	PRICE SENSITIVE	29/07/22	541.28KB	Share
OCC	Updated Investor Presentation		27/07/22	6.08MB	Share
OCC	Striate Global License and Distribution Agreement Update	PRICE SENSITIVE	21/07/22	211.95KB	Share
OCC	Option Terms and Conditions		15/07/22	200.03KB	Share
OCC	Notification regarding unquoted securities - OCC		14/07/22	28.25KB	Share
OCC	Notification regarding unquoted securities - OCC		14/07/22	24.98KB	Share
OCC	Notification of cessation of securities - OCC		29/06/22	22.48KB	Share
OCC	OCC Signs Striate Global License And Manufacturing Agreement	PRICE SENSITIVE	27/06/22	205.1KB	Share
OCC	Trading Halt	PRICE SENSITIVE	24/06/22	553.19KB	Share
OCC	Notification of cessation of securities - OCC		15/06/22	22.48KB	Share
OCC	Final Data Readout for Orthocells Nerve Reconstruction Study	PRICE SENSITIVE	07/06/22	1.06MB	Share
OCC	Orthocell Receives A$2.1m R&D Tax Incentive Refund	PRICE SENSITIVE	03/06/22	188.36KB	Share
OCC	Notification regarding unquoted securities - OCC		12/05/22	27.41KB	Share
OCC	Appendix 4C - Quarterly	PRICE SENSITIVE	29/04/22	672.37KB	Share
OCC	Notification regarding unquoted securities - OCC		21/04/22	28.25KB	Share
OCC	Regulatory Approval for Remplir Nerve Repair Device	PRICE SENSITIVE	21/03/22	295.27KB	Share
OCC	Trading Halt	PRICE SENSITIVE	17/03/22	354.77KB	Share
OCC	Pause in Trading	PRICE SENSITIVE	17/03/22	115.43KB	Share
OCC	Striate US Market Entry Update	PRICE SENSITIVE	28/02/22	185.75KB	Share
OCC	Half Yearly Report and Accounts	PRICE SENSITIVE	23/02/22	1.18MB	Share
OCC	Appendix 4C - Quarterly	PRICE SENSITIVE	31/01/22	728.61KB	Share
OCC	Notice under Section 708(A) of the Corporations Act		30/12/21	146.02KB	Share
OCC	Application for quotation of securities - OCC		30/12/21	24.88KB	Share
OCC	Notice under Section 708(A) of the Corporations Act		23/12/21	146.21KB	Share
OCC	Application for quotation of securities - OCC		23/12/21	24.89KB	Share
OCC	Change of Registry Address		20/12/21	152.9KB	Share
OCC	Notice under Section 708(A) of the Corporations Act		16/12/21	146.23KB	Share
OCC	Application for quotation of securities - OCC		16/12/21	24.88KB	Share
OCC	Successful SmrtGraft Shoulder Study Published	PRICE SENSITIVE	16/12/21	239.16KB	Share
OCC	OrthoATI Tendon Clinical Study Success	PRICE SENSITIVE	08/12/21	1.39MB	Share
OCC	Trading Halt	PRICE SENSITIVE	07/12/21	549.94KB	Share
OCC	Notice under Section 708(A) of the Corporations Act		18/11/21	146.2KB	Share
OCC	Application for quotation of securities - OCC		18/11/21	24.88KB	Share
OCC	Ortho-ATI Shoulder Tendon Study Database Lock	PRICE SENSITIVE	15/11/21	220.73KB	Share
OCC	Notice under Section 708(A) of the Corporations Act		09/11/21	146.19KB	Share
OCC	Application for quotation of securities - OCC		09/11/21	24.91KB	Share
OCC	Appendix 4C - Quarterly	PRICE SENSITIVE	29/10/21	684.82KB	Share
OCC	Presentation - Canaccord Genuity South-West Connect Showcase		28/10/21	4.65MB	Share
OCC	Results of Meeting		27/10/21	138.94KB	Share
OCC	Notification regarding unquoted securities - OCC		26/10/21	27.33KB	Share
OCC	Notification regarding unquoted securities - OCC		26/10/21	27.34KB	Share
OCC	Notification regarding unquoted securities - OCC		26/10/21	25.53KB	Share
OCC	Notification regarding unquoted securities - OCC		26/10/21	23.63KB	Share
OCC	Notification regarding unquoted securities - OCC		26/10/21	23.63KB	Share
OCC	Notice under Section 708(A) of the Corporations Act		18/10/21	146.96KB	Share
OCC	Application for quotation of securities - OCC		18/10/21	24.87KB	Share
OCC	Change of Director's Interest Notices		24/09/21	453.42KB	Share
OCC	Letter to Shareholders - Annual General Meeting		21/09/21	153.27KB	Share
OCC	Notice of Annual General Meeting/Proxy Form		21/09/21	771.03KB	Share
OCC	Notice under Section 708(A) of the Corporations Act		16/09/21	146.22KB	Share

OCC Date of AGM & Closing Date for Director Nominations
04/09/23		110.36KB	Share
OCC Appendix 4G
31/08/23		283.2KB	Share
OCC Corporate Governance Statement
31/08/23		318.09KB	Share
OCC Appendix 4E & Annual Report
31/08/23	PRICE SENSITIVE	6.17MB	Share
OCC Striate re-certified under new European medical device regs
24/08/23	PRICE SENSITIVE	187.74KB	Share
OCC Quarterly Activity Report & Appendix 4C
31/07/23	PRICE SENSITIVE	619.49KB	Share
OCC Orthocell receives A$3.17m R&D tax incentive refund
21/06/23	PRICE SENSITIVE	192.17KB	Share
OCC Change of Director's Interest Notice - Paul Anderson
16/06/23		196.24KB	Share
OCC Change of Director's Interest Notice - Paul Anderson
13/06/23		196.29KB	Share
OCC Initial Director's Interest Notice - John Van Der Wielen
01/06/23		243.04KB	Share
OCC Proposed issue of securities - OCC
29/05/23		24.81KB	Share
OCC Notification regarding unquoted securities - OCC
29/05/23		29.37KB	Share
OCC John Van Der Wielen appointed Independent Non-Exec Chair
29/05/23		230.27KB	Share
OCC Option Terms and Conditions
26/05/23		176.17KB	Share
OCC Notification regarding unquoted securities - OCC
26/05/23		32.74KB	Share
OCC Quarterly Activity Report & Appendix 4C
27/04/23	PRICE SENSITIVE	453.45KB	Share
OCC Cleansing Notice
19/04/23		147.23KB	Share
OCC Application for quotation of securities - OCC
19/04/23		25.11KB	Share
OCC Notification regarding unquoted securities - OCC
19/04/23		31.68KB	Share
OCC Orthocell commences nerve repair study
18/04/23	PRICE SENSITIVE	204.15KB	Share
OCC Leading US-based nerve surgeons appointed to advisory board
29/03/23	PRICE SENSITIVE	169.54KB	Share
OCC Initial Director's Interest Notice-RT
08/03/23		241.27KB	Share
OCC Notification regarding unquoted securities - OCC
08/03/23		28.09KB	Share
OCC Orthocell Appoints Non-Executive Director Dr Ravi Thadhani
08/03/23		231.18KB	Share
OCC Orthocell appoints Company Secretary Mr Peter Webse
01/03/23		132.61KB	Share
OCC Half Yearly Report and Accounts
28/02/23	PRICE SENSITIVE	4.16MB	Share
OCC Investor Presentation
02/02/23		12.22MB	Share
OCC Appendix 4C - Quarterly
30/01/23	PRICE SENSITIVE	456.15KB	Share
OCC Change of Director's Interest Notice PA
23/11/22		196.01KB	Share
OCC Change of Director's Interest Notice LL
23/11/22		197.93KB	Share
OCC Notification of cessation of securities - OCC
23/11/22		22.56KB	Share
OCC Notification of cessation of securities - OCC
23/11/22		22.49KB	Share
OCC Change of Director's Interest Notice LL Revised
11/11/22		320.85KB	Share
OCC Change of Director's Interest Notice LL
09/11/22		198.1KB	Share
OCC Remplir Gains Australian Reimbursement
01/11/22	PRICE SENSITIVE	299.94KB	Share
OCC Appendix 4C - Quarterly
31/10/22	PRICE SENSITIVE	442.67KB	Share
OCC Results of Meeting
28/10/22		140.26KB	Share
OCC Investor Presentation
26/10/22		5.72MB	Share
OCC OrthoATI Rotator Cuff Study Success With Cross-Over Patients
29/09/22	PRICE SENSITIVE	273.87KB	Share
OCC Letter to Shareholders - Annual General Meeting
28/09/22		727.9KB	Share
OCC Notice of Annual General Meeting/Proxy Form
28/09/22		851.1KB	Share
OCC First orders for Striate and Remplir
27/09/22	PRICE SENSITIVE	185.26KB	Share
OCC Appointment of Exclusive Australian Distributor for Remplir
07/09/22	PRICE SENSITIVE	328.63KB	Share
OCC Trading Halt
06/09/22	PRICE SENSITIVE	564.01KB	Share
OCC Annual General Meeting
05/09/22		151.23KB	Share
OCC Appendix 4G
31/08/22		304.06KB	Share
OCC Final Report and Annual Report to Shareholders
31/08/22	PRICE SENSITIVE	5.09MB	Share
OCC Notice under Section 708(A) of the Corporations Act
17/08/22		146.15KB	Share
OCC Notification of cessation of securities - OCC
17/08/22		22.54KB	Share
OCC Application for quotation of securities - OCC
17/08/22		26.67KB	Share
OCC Appendix 4C - Quarterly
29/07/22	PRICE SENSITIVE	541.28KB	Share
OCC Updated Investor Presentation
27/07/22		6.08MB	Share
OCC Striate Global License and Distribution Agreement Update
21/07/22	PRICE SENSITIVE	211.95KB	Share
OCC Option Terms and Conditions
15/07/22		200.03KB	Share
OCC Notification regarding unquoted securities - OCC
14/07/22		28.25KB	Share
OCC Notification regarding unquoted securities - OCC
14/07/22		24.98KB	Share
OCC Notification of cessation of securities - OCC
29/06/22		22.48KB	Share
OCC OCC Signs Striate Global License And Manufacturing Agreement
27/06/22	PRICE SENSITIVE	205.1KB	Share
OCC Trading Halt
24/06/22	PRICE SENSITIVE	553.19KB	Share
OCC Notification of cessation of securities - OCC
15/06/22		22.48KB	Share
OCC Final Data Readout for Orthocells Nerve Reconstruction Study
07/06/22	PRICE SENSITIVE	1.06MB	Share
OCC Orthocell Receives A$2.1m R&D Tax Incentive Refund
03/06/22	PRICE SENSITIVE	188.36KB	Share
OCC Notification regarding unquoted securities - OCC
12/05/22		27.41KB	Share
OCC Appendix 4C - Quarterly
29/04/22	PRICE SENSITIVE	672.37KB	Share
OCC Notification regarding unquoted securities - OCC
21/04/22		28.25KB	Share
OCC Regulatory Approval for Remplir Nerve Repair Device
21/03/22	PRICE SENSITIVE	295.27KB	Share
OCC Trading Halt
17/03/22	PRICE SENSITIVE	354.77KB	Share
OCC Pause in Trading
17/03/22	PRICE SENSITIVE	115.43KB	Share
OCC Striate US Market Entry Update
28/02/22	PRICE SENSITIVE	185.75KB	Share
OCC Half Yearly Report and Accounts
23/02/22	PRICE SENSITIVE	1.18MB	Share
OCC Appendix 4C - Quarterly
31/01/22	PRICE SENSITIVE	728.61KB	Share
OCC Notice under Section 708(A) of the Corporations Act
30/12/21		146.02KB	Share
OCC Application for quotation of securities - OCC
30/12/21		24.88KB	Share
OCC Notice under Section 708(A) of the Corporations Act
23/12/21		146.21KB	Share
OCC Application for quotation of securities - OCC
23/12/21		24.89KB	Share
OCC Change of Registry Address
20/12/21		152.9KB	Share
OCC Notice under Section 708(A) of the Corporations Act
16/12/21		146.23KB	Share
OCC Application for quotation of securities - OCC
16/12/21		24.88KB	Share
OCC Successful SmrtGraft Shoulder Study Published
16/12/21	PRICE SENSITIVE	239.16KB	Share
OCC OrthoATI Tendon Clinical Study Success
08/12/21	PRICE SENSITIVE	1.39MB	Share
OCC Trading Halt
07/12/21	PRICE SENSITIVE	549.94KB	Share
OCC Notice under Section 708(A) of the Corporations Act
18/11/21		146.2KB	Share
OCC Application for quotation of securities - OCC
18/11/21		24.88KB	Share
OCC Ortho-ATI Shoulder Tendon Study Database Lock
15/11/21	PRICE SENSITIVE	220.73KB	Share
OCC Notice under Section 708(A) of the Corporations Act
09/11/21		146.19KB	Share
OCC Application for quotation of securities - OCC
09/11/21		24.91KB	Share
OCC Appendix 4C - Quarterly
29/10/21	PRICE SENSITIVE	684.82KB	Share
OCC Presentation - Canaccord Genuity South-West Connect Showcase
28/10/21		4.65MB	Share
OCC Results of Meeting
27/10/21		138.94KB	Share
OCC Notification regarding unquoted securities - OCC
26/10/21		27.33KB	Share
OCC Notification regarding unquoted securities - OCC
26/10/21		27.34KB	Share
OCC Notification regarding unquoted securities - OCC
26/10/21		25.53KB	Share
OCC Notification regarding unquoted securities - OCC
26/10/21		23.63KB	Share
OCC Notification regarding unquoted securities - OCC
26/10/21		23.63KB	Share
OCC Notice under Section 708(A) of the Corporations Act
18/10/21		146.96KB	Share
OCC Application for quotation of securities - OCC
18/10/21		24.87KB	Share
OCC Change of Director's Interest Notices
24/09/21		453.42KB	Share
OCC Letter to Shareholders - Annual General Meeting
21/09/21		153.27KB	Share
OCC Notice of Annual General Meeting/Proxy Form
21/09/21		771.03KB	Share
OCC Notice under Section 708(A) of the Corporations Act
16/09/21		146.22KB	Share

REFRESH

First 2 3 4 5 6

(20min delay)
Last 61.0¢		Change -0.010(1.61%)		Mkt cap ! $145.8M

Open	High	Low	Value	Volume
62.5¢	63.0¢	61.0¢	$1.181M	1.913M

Buyers (Bids)

No.	Vol.	Price($)
2	5445	61.0¢

Sellers (Offers)

Price($)	Vol.	No.
62.0¢	10000	1

View Market Depth

No.	Vol.	Price($)
1	2987	0.610
11	183967	0.605
19	254835	0.600
5	120224	0.590
2	46005	0.585

Price($)	Vol.	No.
0.620	10000	1
0.625	25000	1
0.630	15000	1
0.635	25000	1
0.645	24000	1

Last trade - 16.10pm 01/11/2024 (20 minute delay)


Last 61.5¢		Change -0.010 ( 0.81 %)
Open	High	Low	Volume
62.5¢	63.0¢	61.0¢	674742
Last updated 15.57pm 01/11/2024 ?

OCC (ASX) Chart

ORTHOCELL LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available